THE GORDIAN KNOT OF TUMOUR IMMUNOLOGY = LE NOEUD GORDIEN DE L'IMMUNOLOGIE TUMORALEAMLOT P.1974; GUY'S HOSP. REP.; G.B.; DA. 1974; VOL. 123; NO 1; PP. 43-51; BIBL. 20REF.Article

DO ALLELES IN LINKAGE DISEQUILIBRIUM COMPENSATE FOR EACH OTHER'S DISADVANTAGEOUS EFFECTS.WELSH KI; AMLOT P; BATCHELOR JR et al.1981; TISSUE ANTIGENS; ISSN 0001-2815; DNK; DA. 1981; VOL. 17; NO 1; PP. 91-96; BIBL. 9 REF.Article

PULMONARY EOSINOPHILIA AND ASTHMA ASSOCIATED WITH CARBAMEZEPINETAK LEE; COCHRANE GM; AMLOT P et al.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; NO 6262; PP. 440; BIBL. 5 REF.Article

Normal immune responses in systemic sclerosisLUPOLI, S; AMLOT, P; BLACK, C et al.Journal of rheumatology. 1990, Vol 17, Num 3, pp 323-327, issn 0315-162XArticle

A new method of iodinating ovalbumin, a protein which lacks accessible tyrosine groups, by conjugation to a highly fluorescent coumarin active ester, CASESAMUEL, D; AMLOT, P. L; ABUKNESHA, R. A et al.Journal of immunological methods. 1985, Vol 81, Num 1, pp 123-130, issn 0022-1759Article

Distinctive development of IgG4 subclass antibodies in the primary and secondary responses to keyhole limpet haemocyanin in manBIRD, P; CALVERT, J. E; AMLOT, P. L et al.Immunology (Oxford). 1990, Vol 69, Num 3, pp 355-360, issn 0019-2805Article

Hodgkin's disease-derived cell lines ― Conflicting clues for the origin of Hodgkin's disease?DREXLER, H. G; AMLOT, P. L; MINOWADA, J et al.Leukemia. 1987, Vol 1, Num 9, pp 629-637, issn 0887-6924Article

Impaired human antibody response to the thymus-independent antigen, DNP-ficoll, after splenectomy. Implications for post-splenectomy infectionsAMLOT, P. L; HAYES, A. E.Lancet (British edition). 1985, Vol 1, Num 8436, pp 1008-1011, issn 0140-6736Article

Splenic dependence of the antibody response to thymus-independent (TI-2) antigensAMLOT, P. L; GRENNAN, D; HUMPHREY, J. H et al.European journal of immunology. 1985, Vol 15, Num 5, pp 508-512, issn 0014-2980Article

Atopy: a favourable prognostic factor for survival in Hodgkin's Disease = Atopie: un facteur pronostique favorable de la survie dans la maladie de HodgkinAMLOT, P. L; SLANEY, J; BROWN, R et al.British journal of cancer. 1983, Vol 48, Num 2, pp 209-215, issn 0007-0920Article

Cytokine nephropathy and multi-organ dysfunction in lymphomaHOLT, S; VARGHESE, Z; JARMULOWICZ, M et al.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, Num 7, pp 1853-1857, issn 0931-0509Article

Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma : a report of three cases and a review of the literatureMUNN, S. E; MCGREGOR, J. M; JONES, A et al.British journal of dermatology (1951). 1996, Vol 135, Num 6, pp 976-981, issn 0007-0963Article

Evaluation of four CD22 antibodies as ricin a chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomasGUO-LIANG SHEN; JIA-LING LI; JANOSSY, G et al.International journal of cancer. 1988, Vol 42, Num 5, pp 792-797, issn 0020-7136Article

The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodiesJIA-LING LI; GUO-LIANG SHEN; VITETTA, E. S et al.Cellular immunology (Print). 1989, Vol 118, Num 1, pp 85-99, issn 0008-8749, 15 p.Article

A single step radial immunodiffusion (RID) method for the quantitation of monomeric IgMCOUGHLAN, R. J; FAITH, A; PANAYI, G. S et al.Journal of clinical & laboratory immunology. 1984, Vol 15, Num 1, pp 51-54, issn 0141-2760Article

Grading of cellular rejection after orthotopic liver transplantationSIDDHARTHA DATTA GUPTA; HUDSON, M; BURROUGHS, A. K et al.Hepatology (Baltimore, Md.). 1995, Vol 21, Num 1, pp 46-57, issn 0270-9139Article

Minimal-change glomerular nephritis : normal kidneys in an abnormal environment ?ABDELGALIL ABDELRAHMAN ALI; WILSON, E; MOORHEAD, J. F et al.Transplantation. 1994, Vol 58, Num 7, pp 849-852, issn 0041-1337Article

Independent clonal origin of T- and B-cell clones in a composite lymphomaDEANE, M; AMLOT, P; PAPPAS, H et al.Leukemia research. 1991, Vol 15, Num 9, pp 811-817, issn 0145-2126, 6 p.Article

The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineageCAMPANA, D; THOMPSON, J. S; AMLOT, P et al.The Journal of immunology (1950). 1987, Vol 138, Num 2, pp 648-655, issn 0022-1767Article

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)MAYER, A; SHARMA, S. K; TOLNER, B et al.British journal of cancer. 2004, Vol 90, Num 12, pp 2402-2410, issn 0007-0920, 9 p.Article

Up-regulation of endoglin on vascular endothelial cells in human solid tumors : implications for diagnosis and therapyBURROWS, F. J; DERBYSHIRE, E. J; TAZZARI, P. L et al.Clinical cancer research. 1995, Vol 1, Num 12, pp 1623-1634, issn 1078-0432Article

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in miceENGERT, A; MARTIN, G; AMLOT, P et al.International journal of cancer. 1991, Vol 49, Num 3, pp 450-456, issn 0020-7136Article

Rearrangement of TCR gamma chain gene involving JP1 suggests early thymocyte origin of peripheral T-cell lymphomaLEBER, B. F; AMLOT, P; HOFFBRAND, A. V et al.European journal of haematology. 1989, Vol 42, Num 4, pp 368-374, issn 0902-4441Article

What delay should there be between primary infectious mononucleosis and renal transplantation?KERECUK, L; AMLOT, P; RIAD, H et al.Pediatric transplantation. 2006, Vol 10, Num 8, pp 970-973, issn 1397-3142, 4 p.Article

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsNASHAN, B; MOORE, R; AMLOT, P et al.Lancet (British edition). 1997, Vol 350, Num 9086, pp 1193-1198, issn 0140-6736Article